Oxiracetam in dementia: a double‐blind, placebo‐controlled study
1992
A multicentre, double-bind, between-patient study was carried out to evaluate the efficacy and tolerability of oxiracetam (800 mg tablet), in comparison with placebo, each given twice daily for 12 weeks to patients suffering from primary degenerative, multi-infarct or mixed dementia. Efficacy was assessed by a neuropsychological batter (simple reaction time, controlled associations, short story, Raven's Progressive Matrices, token test, digit span, word list learning), administered at the beginning and at the end of the study, and by a quality of life scale, administered at entry and after 6 and 12 weeks treatment
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
19
References
30
Citations
NaN
KQI